Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence
Phytomedicine · 2024-01 · 123 · 155248
DOI: 10.1016/j.phymed.2023.155248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytomedicine, 2024-01. Verfasst von Jinfeng Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, the M…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 152 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Multiple sclerosis is a chronic neurodegenerative disease, with main characteristics of pathological inflammation, neural damage and axonal demyelination. Current mainstream treatments demonstrate more or less side effects, which limit their extensive use. PURPOSE: Increasing studies indicate that natural compounds benefit multiple sclerosis without remarkable side effects. Given the needs to explore the potential effects of natural compounds of plant origin on multiple sclerosis and their mechanisms, we review publications involving the role of natural compounds in animal models of multiple sclerosis, excluding controlled trials. STUDY DESIGN AND METHODS: Articles were conducted on PubMed and Web of Science databases using the keywords ``multiple sclerosis'' and ``natural compounds'' published from January 1, 2008, to September 1, 2023. RESULTS: This review summarized the effects of natural ingredients (flavonoids, terpenoids, polyphenols, alkaloids, glycosides, and others) from three aspects: immune regulation, oxidative stress suppression, and myelin protection and regeneration in multiple sclerosis. CONCLUSION: Overall, we concluded 80 studies to show the preclinical evidence that natural compounds may attenuate multiple sclerosis progression via suppressing immune attacks and/or promoting myelin protection or endogenous repair processes. It would pave the roads for the future development of effective therapeutic regiments of multiple sclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, the MOE Innovation Centre for Basic Medicine Research on Qi-Blood TCM Theor…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yuan, J., Tao, Y., Wang, M., Huang, F., & Wu, X. (2024). Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence. Phytomedicine, 123, 155248. https://doi.org/10.1016/j.phymed.2023.155248
Vancouver
Yuan J, Tao Y, Wang M, Huang F, Wu X. Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence. Phytomedicine. 2024;123:155248. doi:10.1016/j.phymed.2023.155248
BibTeX
@article{Yuan2024,
author = {Yuan, Jinfeng and Tao, Yanlin and Wang, Mengxue and Huang, Fei and Wu, Xiaojun},
title = {Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence},
journal = {Phytomedicine},
year = {2024},
volume = {123},
pages = {155248},
doi = {10.1016/j.phymed.2023.155248}
}
EUVIMED